“✒베스트토토안전【평생베스트.com】베스트먹튀✒”的搜索结果，显示 51-60 项，共有 3026 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

4. 血管中心- 临床试验- 妙佑医疗国际

   Rochester, Minn. Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. There is ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma. Needle-based Confocal Laser Endomicroscopy Guided ...

8. 肾病和高血压- 临床试验- 妙佑医疗国际

   Rochester, Minn. As the global epidemic of obesity and diabetes mellitus spreads, an exponential rise in incident chronic kidney disease (CKD) complicated by ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...